New report calls Canada’s alternative protein industry ‘hotbed of innovation and key country to do business in’
Game Changers is the first report to compile Canada’s extensive activity in alternative protein development in one place.
Successfully commercializing health technology requires quality innovation, experienced management, market and technical expertise, and access to sufficient capital.
Genesys Venture Inc.’s team provides clients with the necessary and extensive experience to make this possible.
As a company, GIV helps manage and establish emerging health and biotechnology projects. Founded by renowned bio-entrepreneur Dr. Albert D. Friesen, GVI has an enhanced technology-based business model, where it develops partnership with technology holders and investors to ensure start-ups are successful. GIV also provides its clients with strategic direction, helping them conduct research and business activities.
Using an enhanced incubation model, GVI has experience in providing these services:
In addition to incubation, GVI provides consulting services to industry and public organizations on issues related to health technology and bio-industry development. Where necessary, additional expertise is drawn from GVI's vast personal network.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.